Hideki Origasa

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

Mitsuhiro Yokoyama, Hideki Origasa, Masunori Matsuzaki et al. · The Lancet · 2007 · 2.5K citations

Medicine, Cardiology, Pharmacology +12

Prevalence of atrial fibrillation in the general population of Japan: An analysis based on periodic health examination

Hiroshi Inoue, Akira Fujiki, Hideki Origasa et al. · International Journal of Cardiology · 2008 · 432 citations · Full text

Medicine, Cardiology, Health Sciences +10

Effects of Carvedilol on Heart Failure with Preserved Ejection Fraction: the Japanese Diastolic Heart Failure Study (J-DHF)

Kazuhiro Yamamoto, Hideki Origasa, Masatsugu Hori · European Journal of Heart Failure · 2012 · 350 citations · Full text

Medicine, Cardiology, Pharmacology +12

Japanese Clinical Practice Guideline for Diabetes 2019

Eiichi Araki, Atsushi Goto, Tatsuya Kondo et al. · Journal of Diabetes Investigation · 2020 · 332 citations · Full text

Medicine, Endocrinology, Internal Medicine +15

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)

Yasushi Saitō, Mitsuhiro Yokoyama, Hideki Origasa et al. · Atherosclerosis · 2008 · 319 citations

Medicine, Cardiology, Preventive Medicine +16